Form 4 for CDNA CareDx, Inc.

Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-28 · accession 0001217234-22-000060 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
2022-03-01	2022-03-01	CDNA	Seeto Reginald	See Remarks, Dir	S - Sale	$38.62	-3,153	190.2K	-2%	-$121.8K
2022-03-01	2022-02-28	CDNA	Seeto Reginald	See Remarks, Dir	A - Grant	$0.00	+6,100	196.3K	+3%	$0
2022-03-01	2022-02-28	CDNA	Seeto Reginald	See Remarks, Dir	F - Tax	$38.38	-2,947	193.3K	-2%	-$113.1K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-01	S	D	3,153	$38.62	190,170	D	—	—	(F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.30 to $39.07, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.
2	Common	Common Stock	2022-02-28	A	A	6,100	$0.00	196,270	D	—	—	(F1) The reported securities were represented by restricted performance stock units that were granted on November 2, 2020, 100% of which vested on February 28, 2022 upon the achievement of the requisite performance criteria.
3	Common	Common Stock	2022-02-28	F	D	2,947	$38.38	193,323	D	—	—	(F2) These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.